# Observational Fatty Liver studies recruiting: 39 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 39 trials that are observational for Fatty Liver that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Fatty Liver studies: 39 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/fatty-liver

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 39
- Recruiting or not yet: 39
- Read on: November 19, 2026

## Trials

The 25 newest of 39, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 10, 2026 | NCT07927647 | Immunological Signatures of MASLD and MASH in Patients With Type 1 Diabetes | Assistance Publique - Hôpitaux de Paris | Observational | Not yet recruiting | Type 1 Diabetes Mellitus (T1D), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic... | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927647) |
| October 6, 2026 | NCT07861594 | Lifestyle, Dietary Patterns, and Cardiometabolic Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Among People Living With... | Assiut University | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), HIV Infections, Non-Alcoholic Fatty Liver Disease... | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861594) |
| October 6, 2026 | NCT07860814 | Ultrasound Biomarkers for Assessing Eligibility and Response to Resmetirom Therapy | Radnet Management, Inc. | Observational | Not yet recruiting | Metabolic Dysfunction-steatohepatitis (MASH) | 524 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860814) |
| September 18, 2026 | NCT07827430 | Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLD | Assiut University | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Fatty Liver Disease, Hypothyroidism, Liver... | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07827430) |
| August 20, 2026 | NCT07775638 | Detecting Liver Fibrosis in Patients At-risk | Helse Stavanger HF | Observational | Not yet recruiting | Fatty Liver, NAFLD - Non-Alcoholic Fatty Liver Disease, Nash, MASLD (Metabolic Dysfunction-Associated Steatotic Liver... | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775638) |
| July 30, 2026 | NCT07737340 | Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR) | Sponsor not shown (see the record) | Observational | Recruiting | HIV Infections, Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH), Fatty Liver | 411 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07737340) |
| July 28, 2026 | NCT07731373 | Biomarker Panel for PCOS-Associated Liver Steatosis in Adolescent Girls (COMPASS-pedPCOS) | Kayseri City Hospital | Observational | Not yet recruiting | Polycystic Ovary Syndrome (PCOS), Metabolic Dysfunction-Associated Steatotic Liver Disease, Pediatric Obesity... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07731373) |
| June 17, 2026 | NCT07652892 | Impact of Steatotic Liver Disease Associated With Metabolic Dysfunction (MASLD) on Frailty, Cognition, and Quality of Life. A... | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Observational | Recruiting | Steatosis of Liver | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652892) |
| June 9, 2026 | NCT07636915 | Association Between Fatty Liver and Inflammatory Biomarkers | Sohag University | Observational | Not yet recruiting | Fatty Liver | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636915) |
| March 17, 2026 | NCT07475962 | Prevalence and Risk Factors of Metabolic-Associated Hepatic Steatosis in Individuals Living With Type 1 Diabetes | Institut de Recherches Cliniques de Montreal | Observational | Not yet recruiting | Type 1 Diabetes, Liver Steatoses, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Fibrosis... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07475962) |
| January 28, 2026 | NCT07373769 | Ultrasound Liver Imaging for Classification of Metabolic Dysfunction-associated Steatotic Liver Disease | University of British Columbia | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease | 145 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07373769) |
| January 13, 2026 | NCT07336563 | ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study | Sponsor not shown (see the record) | Observational | Not yet recruiting | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH), Metabolic... | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07336563) |
| January 12, 2026 | NCT07334639 | Metabolic Changes Associated With Weight Gain After Treatment of Achalasia | Assaf-Harofeh Medical Center | Observational | Not yet recruiting | Achalasia, Esophageal | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07334639) |
| January 12, 2026 | NCT07332611 | Long Term Prediction of MASH-related HCC Risk by Proteomics | University Hospital, Bordeaux | Observational | Not yet recruiting | MASH-related HCC | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07332611) |
| January 7, 2026 | NCT07321925 | Thermoacoustic Method for Estimating Liver Fat Fraction | Endra Lifesciences | Observational | Recruiting | MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated... | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07321925) |
| September 23, 2025 | NCT07187830 | Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD | University of Alberta | Observational | Recruiting | Chronic Kidney Disease in Type 2 Diabetes, Obesity & Overweight | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07187830) |
| August 14, 2025 | NCT07122700 | Evaluation of Non-Invasive Tests for Metabolic Liver Disease | Foundation for the National Institutes of Health | Observational | Recruiting | Metabolic Associated Fatty Liver Disease, Metabolic Associated Steatotic Liver Disease, Cirrhosis, Liver, NASH, Liver... | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07122700) |
| May 16, 2025 | NCT06975579 | The COherence of Scatter Identification and Exclusion Algorithm Study | Institute of Cancer Research, United Kingdom | Observational | Recruiting | Steatohepatitis, Nonalcoholic | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06975579) |
| March 10, 2025 | NCT06867172 | Prevalence of Pancreatic Steatosis in Pancreatic Cystic Neoplasms and Pancreatic Adenocarcinoma | Carol Davila University of Medicine and Pharmacy | Observational | Recruiting | Pancreatic Steatosis, Pancreatic Cyst, Pancreatic Adenocarcinoma | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06867172) |
| February 7, 2025 | NCT06814600 | Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients | Centre Hospitalier Universitaire Saint Pierre | Observational | Recruiting | NAFLD, Inflammatory Bowel Diseases, Steatosis, Fibrosis, Liver | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06814600) |
| January 3, 2025 | NCT06757348 | Fatty Liver and Pancreatic Steatosis | Sponsor not shown (see the record) | Observational | Not yet recruiting | Exocrine Pancreatic Insufficiency, Fatty Liver, Nonalcoholic, Pancreatic Steatosis | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06757348) |
| December 18, 2024 | NCT06739486 | Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease | Assiut University | Observational | Not yet recruiting | Non Alcholic Fatty Liver Disease, Hepatic Steatosis, Hepatic Fibrosis, NAFLD (Nonalcoholic Fatty Liver Disease) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06739486) |
| November 27, 2024 | NCT06706856 | Quantitative Ultrasound to Assess Steatotic Liver Disease in Children | University of California, San Diego | Observational | Recruiting | MASLD, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06706856) |
| November 19, 2024 | NCT06694012 | Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 | Osaka Metropolitan University | Observational | Recruiting | Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, Diabetes Mellitus, Hypertension, Hyperglycemia, Hyperlipidemia... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06694012) |
| April 26, 2024 | NCT06386094 | Cardiac Dysfunction in Patients with Fatty Liver Disease | Post Graduate Institute of Medical Education and Research, Chandigarh | Observational | Recruiting | NAFLD, Cardiac Disease, Fatty Liver, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06386094) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Assiut University | 3 |
| Centre Hospitalier Universitaire Saint Pierre | 1 |
| Foundation for the National Institutes of Health | 1 |
| Beijing Jishuitan Hospital | 1 |
| University of California, San Diego | 1 |
| Steno Diabetes Center Copenhagen | 1 |
| Assaf-Harofeh Medical Center | 1 |
| University of Alberta | 1 |
| State University of New York at Buffalo | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| University of Copenhagen | 1 |
| Sohag University | 1 |
| The Affiliated Hospital of Xuzhou Medical University | 1 |
| Endra Lifesciences | 1 |
| Newcastle University | 1 |
| University of British Columbia | 1 |
| Beijing Friendship Hospital | 1 |
| Richmond Research Institute | 1 |
| Kayseri City Hospital | 1 |
| Institute of Cancer Research, United Kingdom | 1 |
| Carol Davila University of Medicine and Pharmacy | 1 |
| Helse Stavanger HF | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 7 |
| China | 4 |
| France | 4 |
| Belgium | 3 |
| Denmark | 3 |
| Italy | 3 |
| Spain | 3 |
| United Kingdom | 3 |
| Canada | 2 |
| Germany | 2 |
| Greece | 2 |
| Netherlands | 2 |
| Portugal | 2 |
| Turkey (Türkiye) | 2 |
| Romania | 2 |
| Argentina | 1 |
| Israel | 1 |
| Egypt | 1 |
| Finland | 1 |
| Sweden | 1 |
| Switzerland | 1 |
| Poland | 1 |
| Norway | 1 |
| India | 1 |
| Japan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Investment management firms in the United States](https://specstream.ai/data/businesses/investment-management-firms/united-states)
- [Caterers in the United States](https://specstream.ai/data/businesses/caterers/united-states)
- [Sri Lankan restaurants in the United States](https://specstream.ai/data/businesses/sri-lankan-restaurants/united-states)
- [Jewelry and watches manufacturers in the United States](https://specstream.ai/data/businesses/jewelry-and-watches-manufacturers/united-states)
- [Chiropractic clinics in the United States](https://specstream.ai/data/businesses/chiropractic-clinics/united-states)
- [T-shirt printers in the United States](https://specstream.ai/data/businesses/t-shirt-printers/united-states)
